Hours in surgery, weeks in hospitals and months of recuperation – or a five-minute procedure under local anesthesia and straight back home with no side effects.
That’s the difference that AI (artificial intelligence) developed in Israel will now be making for patients diagnosed with liver cancer.
Techsomed, a medical imaging startup, allows physicians for the first time to see exactly what’s happening in real time while they destroy (or ablate) a tumor using targeted heat through a needle.
Thermal ablation therapy, a minimally invasive procedure for small tumors, has huge benefits over surgery or chemotherapy for the patients.
Keep reading at israel21c.org.
TechsoMed Founder and CEO Yossi Abu and Chief Strategy Officer Eran Naveh are both Technion alumni.
More Health & Medicine stories
Technion Researchers Find New Alzheimer’s Mechanism
